Legislative Activity

The EARLY Act Reauthorization of 2025 extends the vital Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009. This legislation ensures the continuation of crucial breast health education and awareness programs. Specifically, it reauthorizes the program, pushing its expiration date from 2026 through the year 2031.

The Accelerating the Development of Advanced Psychology Trainees (ADAPT) Act aims to expand Medicare coverage for mental health services provided by qualified doctoral interns and postdoctoral residents under general supervision. This legislation directs the Secretary of Health and Human Services to establish necessary billing codes for Medicare reimbursement one year after enactment. Furthermore, the Act requires the Secretary to issue guidance to states on removing barriers to covering these trainee services under Medicaid and CHIP programs.

The Stop NOAA Closures Act places a temporary moratorium on the closure or restriction of access to any National Oceanic and Atmospheric Administration (NOAA) facilities. This freeze remains in effect until 180 days after key officials submit a required report to Congress detailing the criteria and process for any future facility changes. After the moratorium lifts, any major facility action will still require a 30-day advance notice and justification report to Congress, except in cases of immediate emergency threatening staff safety.

The Medicaid Breast Cancer Access to Treatment Act expands Medicaid eligibility to cover certain individuals who have had breast or cervical cancer. This legislation also mandates that Medicaid coverage must include breast reconstruction surgery following a medically necessary mastectomy. These changes aim to ensure comprehensive care and remove financial barriers for cancer survivors under the program.

The Cosmetic Supply Chain Transparency Act of 2025 enhances cosmetic regulation by requiring detailed ingredient and supply chain information sharing between brand owners and suppliers. This law mandates the FDA to create a public list of harmful, nonfunctional chemical traces that suppliers must eventually test for and certify. Importantly, this federal legislation preserves the right of states to enact stricter ingredient or transparency rules than those established here.

The Asunción Valdivia Heat Illness, Injury, and Fatality Prevention Act of 2025 mandates that employers protect workers from dangerous heat stress by establishing comprehensive safety standards. This Act requires the Secretary of Labor to create evidence-based rules covering engineering controls, administrative procedures, required training, and paid rest breaks to prevent heat-related illness. Furthermore, the law establishes strict enforcement mechanisms, whistleblower protections, and specific timelines for the implementation of these new federal heat protection standards.

The Cosmetic Hazardous Ingredient Right to Know Act of 2025 significantly updates cosmetic regulation by mandating comprehensive ingredient disclosure, especially for fragrances and flavors, on both product labels and brand owner websites. This law requires detailed, machine-readable online ingredient lists and specific hazard warnings on packaging if certain harmful chemicals are present. Importantly, this federal act preserves the authority of states to enact stricter ingredient bans or transparency requirements.

The Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2025 aims to enhance cosmetic safety through targeted research into health disparities affecting communities of color and salon workers. The bill mandates improved access to safety data sheets in multiple languages for professional products and establishes two new National Resource Centers to empower these communities and workers. Finally, it brings synthetic hair braids under FDA cosmetic regulation, requiring new safety standards and labeling.

The Toxic-Free Beauty Act of 2025 establishes new federal standards for cosmetic safety by banning the intentional addition of specific harmful chemicals, such as formaldehyde and certain parabens, in products sold in the U.S. It also sets maximum allowable limits for certain contaminants like 1,4 dioxane and lead. Importantly, this federal legislation does not preempt stricter state laws regarding cosmetic ingredients. These new requirements will take effect for products shipped interstate starting January 1, 2027.

The Uterine Cancer Study Act of 2025 mandates a comprehensive federal study to investigate the potential link between the use of chemical hair straighteners and the risk of developing uterine cancer. This research must specifically examine disparities in cancer rates among women of color. The study will ultimately recommend whether the FDA should require additional safety testing for these hair products.

This bill, titled the Epstein Files Transparency Act, mandates the Attorney General to release nearly all unclassified Department of Justice records related to Jeffrey Epstein within 30 days of enactment. The legislation strictly limits the justifications for withholding or redacting documents, prohibiting secrecy based on political sensitivity or potential embarrassment. The only permissible redactions involve victim privacy, child sexual abuse material, or narrowly defined threats to active investigations or national security classifications. Upon completion, the Attorney General must submit a detailed report to Congress listing all released and withheld materials, including an unredacted list of all named government officials.

The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 aims to improve the detection and treatment of uterine fibroids. It mandates federal research to develop evidence-based early detection strategies and establishes grant programs for states to fund screening, education, and intervention services, prioritizing vulnerable populations. Furthermore, the bill allocates funding for research into pain management related to fibroid surgery and other uterine conditions.

The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025 aims to significantly increase federal research, public education, and provider awareness regarding uterine fibroids. The bill mandates expanded research coordination across federal agencies and authorizes funding to study the condition, which disproportionately affects minority women. It also requires the creation of public awareness campaigns detailing non-hysterectomy treatment options and mandates data collection on Medicaid/CHIP spending for fibroid treatments.

This bill, the Great Lakes Fishery Research Reauthorization Act, extends the authorization for federal funding dedicated to monitoring, assessing, and researching the Great Lakes Basin. It pushes the current funding expiration date from 2025 to the end of fiscal year 2030. This ensures continued support for vital Great Lakes protection and study programs for an additional five years.

The Child Care for Working Families Act establishes comprehensive federal programs to ensure access to high-quality, affordable child care and universal preschool for young children. The legislation creates an entitlement program for child care, mandates that provider reimbursement rates cover actual costs and ensure living wages for staff, and establishes free, universal preschool for 3- and 4-year-olds. Additionally, it provides dedicated funding to stabilize childcare providers and extend the operating hours and compensation for Head Start staff.

The Promoting United States Wireless Leadership Act of 2025 aims to strengthen American influence in global technical standards-setting bodies for wireless technologies like 5G. It directs the Assistant Secretary of Commerce to actively encourage participation from trusted U.S. stakeholders in these groups. This effort specifically requires excluding any entity deemed a threat to U.S. national security. The Act also mandates a strategy briefing to Congress within 60 days of enactment.

This resolution supports the designation of July as Uterine Fibroids Awareness Month to highlight the significant health impact of these common growths on women. It recognizes the disproportionate burden of fibroids on Black and Hispanic women and calls for increased research and improved treatment options. The bill encourages the President to issue a proclamation supporting national awareness activities throughout July.

This resolution expresses support for designating July 10th as Journeyman Lineworkers Recognition Day. It honors the essential and dangerous work performed by these skilled professionals, especially their heroic efforts in restoring power after major disasters. The day serves to recognize their service and remember those who have lost their lives performing this vital work.

The Pharmacy Benefit Manager Reform Act of 2025 aims to increase transparency and accountability across the prescription drug supply chain. It mandates fairer pharmacy network access for Medicare beneficiaries and imposes strict new financial reporting and service fee requirements on Pharmacy Benefit Managers (PBMs) working with Medicare and private health plans. Furthermore, the bill establishes new federal mechanisms to accurately track drug acquisition costs in Medicaid and explicitly bans the practice of "spread pricing" in state Medicaid contracts.

The Expanding Access to Mental Health Services in Schools Act of 2025 establishes a new federal grant program to increase the number of mental health professionals in high-need school districts. This funding is specifically designed to help eligible agencies recruit, hire, and retain school counselors, psychologists, and social workers. Grantees must demonstrate a plan to improve student-to-provider ratios and report annually on staffing improvements and provider retention.